Humanitarian device exemption (HDE)
A Humanitarian Device Exemption (HDE) is an FDA marketing pathway for a Humanitarian Use Device treating rare conditions, approving it based on demonstrated safety and probable benefit rather than the full effectiveness evidence required for standard approval.
What is a Humanitarian Device Exemption (HDE)?
A Humanitarian Device Exemption (HDE) is a U.S. Food and Drug Administration (FDA) marketing pathway designed for devices that treat or diagnose conditions affecting only a small number of patients each year. It allows such a device, known as a Humanitarian Use Device, to reach the market without the full effectiveness data normally required for approval.
Instead of proving effectiveness through large clinical trials, the applicant must show that the device is safe and that its probable benefit outweighs its risks. This lower evidentiary bar acknowledges that rare-disease populations are often too small to support conventional studies.
Why does the HDE pathway matter?
Without a tailored route to market, manufacturers would have little economic or scientific incentive to develop devices for very rare conditions, leaving those patients with few options. The HDE lowers that barrier so that promising technologies can become available.
Because approval rests on probable benefit rather than demonstrated effectiveness, devices cleared this way often carry specific use conditions, and many require oversight by an institutional review board when used. This balances access for rare-disease patients against the need for continued safety vigilance.
- humanitarian device exemption
- what is an hde
- hde fda pathway
- humanitarian device exemption definition
- hde vs pma
- fda hde approval